Skip to content

Tag Archives: Holistic Medicine Sarasota Fl

Ozone Therapy Research Roundup: Wound Care, Stroke Recovery, and Cancer Support

Ozone therapy continues to draw growing peer-reviewed research interest as a complementary tool in integrative medicine. Here’s a roundup of recent notable developments spanning a new wearable delivery device, stroke recovery data, and cancer-support applications.

Table of Contents A Wearable Approach to Drug-Resistant Wounds Stroke Recovery Data Ozone as Complementary Cancer Support Faster Healing for Chronic Facial Wounds Why Continue reading

Posted in What We Treat | Also tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Comments Off on Ozone Therapy Research Roundup: Wound Care, Stroke Recovery, and Cancer Support

FDA Advisory Committee to Review Cell Therapy for Duchenne Muscular Dystrophy

The FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee meets July 29 to review Capricor Therapeutics’ deramiocel, an investigational allogeneic cell therapy for Duchenne muscular dystrophy. The meeting comes ahead of an August 22 target decision date and follows a prior rejection of the company’s first application.

Table of Contents What’s Happening How Deramiocel Works What the Data Show Why Continue reading

Posted in What We Treat | Also tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Comments Off on FDA Advisory Committee to Review Cell Therapy for Duchenne Muscular Dystrophy

FDA Approves Tregzi, First Regulatory T-Cell Therapy to Reduce Chronic GVHD

The FDA has approved Tregzi, a precision-engineered cell therapy from Orca Bio, as the first regulatory T-cell (Treg) based treatment for adults undergoing allogeneic stem cell transplants for blood cancers. Trial data showed it more than doubled one-year survival free of chronic graft-versus-host disease compared with standard transplants.

Table of Contents What Happened How Tregzi Works What the Data Show Continue reading

Posted in What We Treat | Also tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Comments Off on FDA Approves Tregzi, First Regulatory T-Cell Therapy to Reduce Chronic GVHD

FDA Grants RMAT Status to Allocetra, a Cell Therapy for Knee Osteoarthritis

FDA Grants RMAT Status to Allocetra, a Cell Therapy for Knee Osteoarthritis

The FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to Allocetra, an investigational cell therapy from Enlivex, for age-related symptomatic knee osteoarthritis in adults 64 and older. The designation is based on six-month data showing durable improvements in pain and function.

What Happened

The FDA has granted Continue reading

Posted in Uncategorized | Also tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Comments Off on FDA Grants RMAT Status to Allocetra, a Cell Therapy for Knee Osteoarthritis

Beyond Mold: A Complete Guide to Biotoxin Illness (CIRS) and How to Recover

If you have spent months or years cycling through specialists, collecting vague diagnoses like fibromyalgia or chronic fatigue syndrome, and feeling as though your body has become a stranger to you, you are not alone. You may be dealing with Biotoxin Illness/CIRS, a condition Continue reading

Posted in What We Treat | Also tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Comments Off on Beyond Mold: A Complete Guide to Biotoxin Illness (CIRS) and How to Recover
941-444-6336 Directions